Table 3.
Odds ratio | 95% Confidence interval | p | |
---|---|---|---|
Clinical tumor stage cT |
1.23 | (1.10–1.38) | ≤ 0.001 |
Clinical tumor stage cN (cN0 vs. cN +) |
1.02 | (0.81–1.27) | 0.88 |
BMI | 0.997 | (0.977–1.02) | 0.78 |
Age | 1.00 | (0.997–1.01) | 0.26 |
Tumor subtype | 0.007 | ||
Luminal A (served as reference category) | |||
Luminal B | 0.71 | (0.59–0.87) | ≤ 0.001 |
HER2 positive | 0.95 | (0.54–1.68) | 0.86 |
Triple negative | 1.01 | (0.68–1.50) | 0.97 |
Grading | 0.26 | ||
G1 (served as reference category) | |||
G2 | 1.23 | (0.93–1.64) | 1.23 |
G3 | 1.09 | (0.78–1.51) | 1.09 |
Histology | |||
NST (served as reference category) | |||
Invasive lobular | 0.96 | (0.75–1.21) | 0.71 |
Other | 1.09 | (0.73–1.64) | 0.68 |
Ki67 | 1.00 | (0.995–1.01) | 0.82 |
All variables were tested in univariable binary logistic regression first